Organisms

Vedanta Biosciences’ Silvia Caballero, Ph.D., Named as an MIT Technology Review Global Innovator Under 35

Retrieved on: 
Tuesday, June 25, 2019
Biotechnology, Pharmaceutical, Health, Branches of biology, Bacteriology, Microbiology, Organisms, Environmental microbiology, Bacteria, Human microbiota, Microbiota, David Berry

Vedanta Biosciences , a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced that a Vedanta scientific team member, Silvia Caballero, Ph.D., has been named as one of MIT Technology Reviews Global Innovators Under 35 .

Key Points: 
  • Vedanta Biosciences , a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced that a Vedanta scientific team member, Silvia Caballero, Ph.D., has been named as one of MIT Technology Reviews Global Innovators Under 35 .
  • In 2018, Dr. Caballero was named Pioneer of the Year for MIT Technology Reviews Innovators Under 35 for Latin America.
  • Vedanta Biosciences is a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria.
  • Vedanta Biosciences is a leader in the microbiome field with capabilities and deep expertise to discover, develop, and manufacture live bacteria drugs.

Kanazawa University Research: Structural Development of the Brain

Retrieved on: 
Monday, June 24, 2019
Animal models, American football in Japan, Kanazawa, Kanazawa University, Organisms, Melanogaster, Drosophila melanogaster, Drosophila, Animals, Fruit fly, Insects

The team spanning across Kanazawa University, Ryukoku University, Tokyo Institute of Technology and Imperial College London, used the Drosophila melanogaster (fruit fly) brain for their experiments.

Key Points: 
  • The team spanning across Kanazawa University, Ryukoku University, Tokyo Institute of Technology and Imperial College London, used the Drosophila melanogaster (fruit fly) brain for their experiments.
  • The visual centre of the Drosophila brain bears high structural resemblance to the columnar arrangement of the human one, making it an apposite, yet simple model to study.
  • The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture.
  • Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Kanazawa University Research: Structural Development of the Brain

Retrieved on: 
Monday, June 24, 2019
Animal models, Animals, Organisms, American football in Japan, Kanazawa University, Melanogaster, Drosophila melanogaster, Brain, Kanazawa, Drosophila, Branches of biology

The team spanning across Kanazawa University, Ryukoku University, Tokyo Institute of Technology and Imperial College London, used the Drosophila melanogaster (fruit fly) brain for their experiments.

Key Points: 
  • The team spanning across Kanazawa University, Ryukoku University, Tokyo Institute of Technology and Imperial College London, used the Drosophila melanogaster (fruit fly) brain for their experiments.
  • This discovery can help neuroscientists monitor healthy development of the brain and uncover other molecules involved in the process.
  • The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture.
  • Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Banfield Pet Hospital®'s Ninth Annual State Of Pet Health Report® Tackles Weighty Issue Of Osteoarthritis

Retrieved on: 
Thursday, June 20, 2019
Animals, Banfield Pet Hospital, Banfield, Osteoarthritis, Pet, Dog, Organisms

VANCOUVER, Wash., June 20, 2019 /PRNewswire/ --Today, Banfield Pet Hospital released its 2019 State of Pet Health Report , which explores the growing trend of osteoarthritis (OA) in pets a progressive and painful degenerative disease that can go unnoticed and undiagnosed.

Key Points: 
  • VANCOUVER, Wash., June 20, 2019 /PRNewswire/ --Today, Banfield Pet Hospital released its 2019 State of Pet Health Report , which explores the growing trend of osteoarthritis (OA) in pets a progressive and painful degenerative disease that can go unnoticed and undiagnosed.
  • According to the report, Banfield has witnessed a 66% increase of OA in dogs and 150% increase in catsover the past 10 years.
  • Discomfort from OA can keep pets from being active, lead to weight gain, and in turn, worsen the joint condition.
  • Other key findings from Banfield's 2019 State of Pet Health Report include:
    The largest of its kind, Banfield's 2019 State of Pet Health Report leverages medical data from the more than 2.5 million dogs and 500,000 cats Banfield cared for in 2018.

Redfin and Trupanion Name the 25 Most Cat-Friendly Cities of 2019

Retrieved on: 
Thursday, June 20, 2019
Animals, Redfin, Cat, Pet, Organisms, Species

SEATTLE, June 20, 2019 /PRNewswire/ --(NASDAQ: RDFN) Corvallis, OR; Spokane, WA; and Orlando, FL are the best cities for cat lovers in 2019, according to a new ranking from Redfin ( www.redfin.com ), the technology powered real estate brokerage, and Trupanion ( www.trupanion.com ), a leader in high-quality medical insurance for pets.

Key Points: 
  • SEATTLE, June 20, 2019 /PRNewswire/ --(NASDAQ: RDFN) Corvallis, OR; Spokane, WA; and Orlando, FL are the best cities for cat lovers in 2019, according to a new ranking from Redfin ( www.redfin.com ), the technology powered real estate brokerage, and Trupanion ( www.trupanion.com ), a leader in high-quality medical insurance for pets.
  • To determine the ranking, which looked at 250 cities nationwide, Trupanion analyzed its data on access to cat-specific services such as clinics, shelters and hospitals, as well as environmental hazards.
  • "Certain homes are better suited to cats, with spaces for the furry family member to lounge and play, and nearby facilities to maintain your cat's health.
  • Here is Redfin and Trupanion's definitive ranking for the most cat-friendly cities of 2019:

30-Year Life Sciences Veteran Don Enns Joins Microbiome Insights Board of Directors

Retrieved on: 
Tuesday, June 18, 2019
Health, Biotechnology, Professional services, Human resources, Branches of biology, Biology, Microbiology, Organisms, Bacteriology, Bacteria, Microbiota, DNA sequencing, Bioinformatics

Microbiome Insights, Inc., a leading provider of microbiome DNA sequencing and bioinformatic analysis, today announced the appointment of Mr. Don Enns as an independent member to its Board of Directors.

Key Points: 
  • Microbiome Insights, Inc., a leading provider of microbiome DNA sequencing and bioinformatic analysis, today announced the appointment of Mr. Don Enns as an independent member to its Board of Directors.
  • "Don is a very experienced and highly-regarded business leader in the life sciences industry, and is known for building value in companies," says Mr. Malcolm Kendall, Microbiome Insights Chief Executive Officer.
  • The appointment of Enns coincides with the end of Dr. Pieter Culliss tenure as a member of the Board of Directors for Microbiome Insights.
  • Microbiome Insights, Inc. is a global provider of end-to-end services for microbiome DNA sequencing and state-of-the-art bioinformatic analysis.

Despite Eagerness to Engage in Ecosystems, Few Insurers are Well-Positioned to Succeed as Ecosystem Partners, Accenture Study Finds

Retrieved on: 
Tuesday, June 18, 2019
Professional services, Finance, Insurance, Systems ecology, Ecosystem, Superorganisms, Symbiosis, Biology, Nature, Organisms

However, despite this enthusiasm and desire to compete in ecosystems, insurers are falling short on having the right capabilities, culture and technologies to fully exploit ecosystem opportunities.

Key Points: 
  • However, despite this enthusiasm and desire to compete in ecosystems, insurers are falling short on having the right capabilities, culture and technologies to fully exploit ecosystem opportunities.
  • This ranks the insurance industry second-to-last among the dozen industries analyzed in terms of the number of ecosystem masters.
  • Joining or designing market-leading ecosystems will enable insurers to ride the disruption wave, instead of being swept up in it.
  • Encouragingly, the overwhelming majority (97%) of insurers surveyed believe they have what it takes to become an attractive ecosystem partner.

Visiongain Report Looks at Opportunities Within the $1bn Human Microbiome Therapeutics Market

Retrieved on: 
Tuesday, June 18, 2019
Branches of biology, Bacteriology, Microbiology, Organisms, Environmental microbiology, Bacteria, Microbiota, Human microbiota, SWOT analysis

Qualitative analysis of the human microbiome therapeutics market in the form of a SWOT Analysis.

Key Points: 
  • Qualitative analysis of the human microbiome therapeutics market in the form of a SWOT Analysis.
  • What are the market shares of the submarkets for gastrointestinal disorders, infectious diseases, metabolic diseases, dermatological conditions, and other disorders from the overall human microbiome therapeutics market?
  • How will the market shares for each of the submarkets within the human microbiome therapeutics market develop from 2019 to 2029?
  • How will the regional market shares in the human microbiome therapeutics market change by 2029 and which geographical region will lead the market in 2029?

Visiongain Report Looks at Opportunities Within the $1bn Human Microbiome Therapeutics Market

Retrieved on: 
Tuesday, June 18, 2019
Branches of biology, Bacteriology, Microbiology, Organisms, Environmental microbiology, Bacteria, Microbiota, Human microbiota, SWOT analysis

Qualitative analysis of the human microbiome therapeutics market in the form of a SWOT Analysis.

Key Points: 
  • Qualitative analysis of the human microbiome therapeutics market in the form of a SWOT Analysis.
  • What are the market shares of the submarkets for gastrointestinal disorders, infectious diseases, metabolic diseases, dermatological conditions, and other disorders from the overall human microbiome therapeutics market?
  • How will the market shares for each of the submarkets within the human microbiome therapeutics market develop from 2019 to 2029?
  • How will the regional market shares in the human microbiome therapeutics market change by 2029 and which geographical region will lead the market in 2029?

Intralytix, the Eliava Foundation and Ferring Pharmaceuticals Sign Joint Collaboration Agreement for Reproductive Medicine and Women's Health Initiatives

Retrieved on: 
Monday, June 17, 2019
Bacteriophages, Microbiology, Academic journals, George Eliava Institute, Organisms, Eliava, Bacteriophage, Ferring Pharmaceuticals, Phage therapy, Virology, George Eliava

This alliance is the first step in our investigation of a series of potential bacteriophage-based solutions to help manage many women's health-associated indications."

Key Points: 
  • This alliance is the first step in our investigation of a series of potential bacteriophage-based solutions to help manage many women's health-associated indications."
  • "We are thrilled to extend our existing collaboration network in the field of Bacteriophage Therapy and to engage the Eliava Foundation together with Intralytix for developing bacteriophage-based treatments in the field of Reproductive Medicine and Women's Health,"remarked Mirjam Mol-Arts, Senior Vice President of Global Development at Ferring Pharmaceuticals.
  • Eliava Foundation is a non-for-profit organization founded by the scientists of the Eliava Institute of Bacteriophages, Microbiology and Virology (IBMV), located in Tbilisi, Republic of Georgia.
  • To learn more about the Eliava Foundation and Eliava Institute please visit http://eliava-institute.org/
    Ferring Pharmaceuticals is a privately owned, international pharmaceutical company headquartered in St. Prex, Switzerland.